Nike
NKE
34.36
-0.25
-0.72%
Nike
US · NKE
#423 by market cap
Listed 1980
34.36
-0.25
-0.72%
Live - 5344 symbols - heartbeat 131s ago
· 2026-10-08 08:40
Pre-market
34.12
-0.70%
After-hours
34.30
-0.17%
Overnight
34.15
-0.61%
- Market cap
- 51.04B
- P/E (TTM)i
- 16.44
- P/Bi
- 3.35
- EPSi
- 2.10
- Div yieldi
- 4.77%
- 52W posi
- 7%
Reader sentiment
Are you bullish or bearish on NKE?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.21, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +0.19% YoY
Margins
- Gross margin
- 42.91%
- Operating margin
- 8.18%
- Net margin
- 6.70%
Key ratios & quality
- Enterprise valuei
- 50.43B
- Altman Z-Scorei
- 3.21
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 39.12B | 37.40B | 44.54B | 46.71B | 51.22B | 51.36B | 46.31B | 46.40B |
| Gross profit | 17.47B | 16.24B | 19.96B | 21.48B | 22.29B | 22.89B | 19.79B | 19.91B |
| Selling & admin expenses | 12.70B | 13.13B | 13.03B | 14.80B | 16.38B | 16.58B | 16.09B | 16.11B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 4.77B | 3.12B | 6.94B | 6.68B | 5.92B | 6.31B | 3.70B | 3.80B |
| Pretax profit | 4.80B | 2.89B | 6.66B | 6.65B | 6.20B | 6.70B | 3.89B | 3.90B |
| Tax | 772.00M | 348.00M | 934.00M | 605.00M | 1.13B | 1.00B | 666.00M | 792.00M |
| Net profit | 4.03B | 2.54B | 5.73B | 6.05B | 5.07B | 5.70B | 3.22B | 3.11B |
| Basic EPS | 3 | 2 | 4 | 4 | 3 | 4 | 2 | 2 |
| Diluted EPS | 2.49 | 1.60 | 3.56 | 3.75 | 3.23 | 3.73 | 2.16 | 2.10 |
| Line item | 2025-02 | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 |
|---|---|---|---|---|---|---|
| Revenue | 11.27B | 11.10B | 11.72B | 12.43B | 11.28B | 10.97B |
| Gross profit | 4.68B | 4.47B | 4.94B | 5.05B | 4.53B | 5.39B |
| Selling & admin expenses | 3.89B | 4.15B | 4.02B | 4.04B | 3.98B | 4.08B |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 788.00M | 321.00M | 927.00M | 1.01B | 553.00M | 1.31B |
| Pretax profit | 844.00M | 318.00M | 922.00M | 999.00M | 650.00M | 1.33B |
| Tax | 50.00M | 107.00M | 195.00M | 207.00M | 130.00M | 260.00M |
| Net profit | 794.00M | 211.00M | 727.00M | 792.00M | 520.00M | 1.07B |
| Basic EPS | 1 | 0 | 0 | 1 | 0 | 1 |
| Diluted EPS | 0.54 | 0.14 | 0.49 | 0.53 | 0.35 | 0.72 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 16.53B | 20.56B | 26.29B | 28.21B | 25.20B | 25.38B | 23.36B | 24.60B |
| Cash & ST investments | 4.66B | 8.79B | 13.48B | 13.00B | 10.68B | 11.58B | 9.15B | 9.03B |
| Inventory | 5.62B | 7.37B | 6.85B | 8.42B | 8.45B | 7.52B | 7.49B | 7.50B |
| Total assets | 23.72B | 31.34B | 37.74B | 40.32B | 37.53B | 38.11B | 36.58B | 38.41B |
| Total current liabilities | 7.87B | 8.28B | 9.67B | 10.73B | 9.26B | 10.59B | 10.57B | 12.55B |
| Short-term debt | 15.00M | 696.00M | 469.00M | 930.00M | 431.00M | 1.48B | 502.00M | 2.48B |
| Long-term debt | 3.46B | 9.41B | 9.41B | 8.92B | 8.93B | 7.90B | 7.96B | 5.94B |
| Total liabilities | 14,677,000,000.00 | 23,287,000,000.00 | 24,973,000,000.00 | 25,040,000,000.00 | 23,527,000,000.00 | 23,680,000,000.00 | 23,366,000,000.00 | 23,545,000,000.00 |
| Total equity | 9.04B | 8.06B | 12.77B | 15.28B | 14.00B | 14.43B | 13.21B | 14.87B |
| Retained earnings | 1.64B | -191.00M | 3.18B | 3.48B | 1.36B | 965.00M | -727.00M | -155.00M |
| Line item | 2025-02 | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 |
|---|---|---|---|---|---|---|
| Total current assets | 24.61B | 23.36B | 23.90B | 24.02B | 23.18B | 24.60B |
| Cash & ST investments | 10.39B | 9.15B | 8.58B | 8.35B | 8.06B | 9.03B |
| Inventory | 7.54B | 7.49B | 8.11B | 7.73B | 7.49B | 7.50B |
| Total assets | 37.79B | 36.58B | 37.33B | 37.79B | 37.06B | 38.41B |
| Total current liabilities | 11.22B | 10.57B | 10.91B | 11.64B | 10.84B | 12.55B |
| Short-term debt | 1.48B | 502.00M | 510.00M | 1.51B | 1.49B | 2.48B |
| Long-term debt | 7.96B | 7.96B | 8.00B | 7.02B | 7.03B | 5.94B |
| Total liabilities | 23,786,000,000.00 | 23,366,000,000.00 | 23,866,000,000.00 | 23,702,000,000.00 | 22,974,000,000.00 | 23,545,000,000.00 |
| Total equity | 14.01B | 13.21B | 13.47B | 14.09B | 14.09B | 14.87B |
| Retained earnings | -175.00M | -727.00M | -700.00M | -519.00M | -610.00M | -155.00M |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 5.90B | 2.49B | 6.66B | 5.19B | 5.84B | 7.43B | 3.70B | 2.87B |
| Depreciation & amortization | 720.00M | 1.12B | 797.00M | 840.00M | 859.00M | 844.00M | 808.00M | 797.00M |
| Free cash flow | 4.78B | 1.40B | 5.96B | 4.43B | 4.87B | 6.62B | 3.27B | 2.18B |
| Dividends paid | -1.33B | -1.45B | -1.64B | -1.84B | -2.01B | -2.17B | -2.30B | -2.41B |
| Stock buybacks / issuance | -4.29B | -3.07B | -608.00M | -4.01B | -5.48B | -4.25B | -2.99B | -146.00M |
| Ending cash balance | 4.47B | 8.35B | 9.89B | 8.57B | 7.44B | 9.86B | 7.46B | 7.56B |
| Line item | 2025-02 | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 |
|---|---|---|---|---|---|---|
| Operating cash flow | 1.79B | 463.00M | 222.00M | 579.00M | 430.00M | 1.64B |
| Depreciation & amortization | 242.00M | 197.00M | 198.00M | 180.00M | 216.00M | 203.00M |
| Free cash flow | 1.71B | 363.00M | 15.00M | 386.00M | 284.00M | 1.50B |
| Dividends paid | -594.00M | -591.00M | -591.00M | -598.00M | -609.00M | -609.00M |
| Stock buybacks / issuance | -506.00M | -199.00M | -126.00M | -20.00M | 0 | 0 |
| Ending cash balance | 8.60B | 7.46B | 7.02B | 6.97B | 6.66B | 7.56B |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 42.74 | 29.70 | 55.01 | 43.11 | 34.63 | 40.09 | 23.29 | 22.14 |
| ROA %i | 17.42 | 9.22 | 16.58 | 15.49 | 13.02 | 15.07 | 8.62 | 8.29 |
| ROIC %i | 30.83 | 15.12 | 24.55 | 22.61 | 18.76 | 21.70 | 12.72 | 12.40 |
| 5-year avg ROE %i | 30.49 | 30.87 | 35.85 | 37.59 | 41.04 | 40.51 | 39.23 | 32.65 |
| EBIT margin %i | 12.20 | 8.33 | 15.58 | 14.29 | 11.55 | 12.29 | 7.99 | 8.18 |
| FCF / sales %i | 12.23 | 3.74 | 13.39 | 9.48 | 9.51 | 12.88 | 7.06 | 4.71 |
| Current ratioi | 2.10 | 2.48 | 2.72 | 2.63 | 2.72 | 2.40 | 2.21 | 1.96 |
| Quick ratioi | 1.14 | 1.39 | 1.85 | 1.65 | 1.60 | 1.51 | 1.31 | 1.19 |
| Debt / assetsi | 14.67 | 41.53 | 33.95 | 31.32 | 32.36 | 31.36 | 30.11 | 28.72 |
| LT debt / equityi | 38.32 | 152.94 | 96.69 | 76.55 | 83.64 | 72.55 | 79.55 | 57.55 |
| Interest coveragei | -- | -- | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | 6.51 | 2.88 | 6.96 | 6.09 | 11.05 | 4.87 | -0.29 | -3.24 |
| Net income CAGR (3Y) %i | 2.33 | -15.71 | 43.63 | 14.49 | 25.93 | -0.16 | -18.95 | -15.05 |
| FCF CAGR (3Y) %i | 28.47 | -20.08 | 14.93 | -2.53 | 51.58 | 3.54 | -9.64 | -23.47 |
| Line item | 2025-02 | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 |
|---|---|---|---|---|---|---|
| ROE %i | 31.93 | 23.29 | 21.12 | 17.95 | 16.02 | 22.14 |
| ROA %i | 12.00 | 8.62 | 7.70 | 6.66 | 6.01 | 8.29 |
| ROIC %i | 17.26 | 12.72 | 11.44 | 9.81 | 8.79 | 12.40 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 10.30 | 7.99 | 7.36 | 6.54 | 6.03 | 8.18 |
| FCF / sales %i | 11.11 | 7.06 | 6.48 | 5.32 | 2.25 | 4.71 |
| Current ratioi | 2.19 | 2.21 | 2.19 | 2.06 | 2.14 | 1.96 |
| Quick ratioi | 1.33 | 1.31 | 1.24 | 1.21 | 1.24 | 1.19 |
| Debt / assetsi | 31.52 | 30.11 | 29.63 | 29.86 | 30.16 | 28.72 |
| LT debt / equityi | 74.48 | 79.55 | 78.34 | 69.36 | 68.74 | 57.55 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Footwear is the largest reported line at 65.82% of revenue, across 4 reported segments.
- Apparel follows at 29.09%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Footwear65.82%
Apparel29.09%
Equipment4.78%
Other0.31%
Region
North America44.21%
Europe, Middle East & Africa27.10%
Asia Pacific & Latin America13.46%
Greater China12.60%
Converse2.53%
Global Brand Divisions0.11%
Quote time 2026-10-08 08:40:15 · For reference only, not investment advice and not tailored to your situation.